Walleye Capital
IBIO icon

Walleye Capital’s iBio IBIO Stock Holding History

Walleye Capital’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Buy
500,375
+111,821
+29% +$200K ﹤0.01% 2237
2026
Q1 		$738K Buy
388,554
+190,179
+96% +$441K ﹤0.01% 2351
2025
Q4 		$383K Buy
+198,375
New +$271K ﹤0.01% 3124

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Walleye Capital's IBIO Position: Q2 2026 in Review

Walleye Capital increased its iBio (IBIO) stake by 29% in Q2 2026, buying an estimated $200K and bringing the position to 500,375 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

Walleye Capital first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Walleye Capital held 500,375 shares of iBio worth $876K as of Q2 2026.
  • Walleye Capital bought 111,821 iBio shares in Q2 2026, an estimated $200K.
  • iBio made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2237 holding.
  • Walleye Capital first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.